Literature DB >> 17188156

Lymph node metastases in differentiated thyroid cancer under 2 cm.

Rishindra M Reddy1, Perry W Grigsby, Jeffrey F Moley, Bruce L Hall.   

Abstract

BACKGROUND: The goal of this study was to evaluate the presence of lymph node metastasis in patients with T1 differentiated thyroid cancer (DTC) and determine prognostic significance for tumor recurrence and cancer-related death.
METHODS: From a prospective tumor registry, we reviewed data from 551 patients with DTC who underwent total or subtotal thyroidectomy and who had primary tumor size </=2 cm. Patients received standard radioactive iodine ablation.
RESULTS: The proportion of patients with lymph node metastasis was 45%. This percentage remained the same in a comparison of tumors from 0 to 1 cm with tumors from 1 to 2 cm. Logistic regression analyses did not identify primary tumor size as a predictor of lymph node metastasis, but did show that histologic vascular invasion and soft tissue invasion correlated with positive lymph nodes. Multifocal disease approached significance. Actuarial estimates for first recurrence displayed a significant difference in patients who had positive cervical lymph nodes versus negative nodes: 56% versus 71% disease-free at 20 years. There was no difference in cancer-related death.
CONCLUSIONS: In T1 DTC, lymph node metastasis does not correlate with tumor size but does correlate with vascular/soft tissue invasion. Patients with positive lymph nodes have a higher recurrence risk, but no significant increase in death.

Entities:  

Mesh:

Year:  2006        PMID: 17188156     DOI: 10.1016/j.surg.2006.08.010

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  11 in total

1.  Comparison between preconsultation ultrasonography and office surgeon-performed ultrasound in patients with thyroid cancer.

Authors:  Denise Carneiro-Pla; Sonesh Amin
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

2.  Does the T1 subdivision correlate with the risk of recurrence of papillary thyroid cancer?

Authors:  Nathalie Chereau; Christophe Trésallet; Severine Noullet; Gaelle Godiris-Petit; Frédérique Tissier; Laurence Leenhardt; Fabrice Menegaux
Journal:  Langenbecks Arch Surg       Date:  2016-03-08       Impact factor: 3.445

3.  Should small papillary thyroid cancer be observed? A population-based study.

Authors:  Naris Nilubol; Electron Kebebew
Journal:  Cancer       Date:  2014-11-25       Impact factor: 6.860

4.  Pattern of regional metastases and prognostic factors in differentiated thyroid carcinoma.

Authors:  G Spriano; P Ruscito; R Pellini; M Appetecchia; R Roselli
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-12       Impact factor: 2.124

5.  Genotypes of Papillary Thyroid Carcinoma With High Lateral Neck Metastasis in Chinese Population.

Authors:  Wei Guo; Junwei Huang; Taiping Shi; Hanyuan Duan; Xiaohong Chen; Zhigang Huang
Journal:  Front Oncol       Date:  2022-07-05       Impact factor: 5.738

Review 6.  Prognostic utility of BRAF mutation in papillary thyroid cancer.

Authors:  Mingzhao Xing
Journal:  Mol Cell Endocrinol       Date:  2009-10-31       Impact factor: 4.102

7.  Adequacy of pathology reports of specimens from patients with differentiated thyroid cancer.

Authors:  Ma Luisa Isidro; Gloria Lugo; Olga Fidalgo; Sara García-Arias
Journal:  Endocr Pathol       Date:  2012-12       Impact factor: 3.943

8.  BRAF mutation in papillary thyroid microcarcinoma: the promise of better risk management.

Authors:  Mingzhao Xing
Journal:  Ann Surg Oncol       Date:  2009-01-22       Impact factor: 5.344

9.  The association between tumor's location and cervical lymph nodes metastasis in papillary thyroid cancer.

Authors:  Ting-Ting Zhang; Xiu-Zhu Qi; Jian-Ping Chen; Rong-Liang Shi; Shi-Shuai Wen; Yu-Long Wang; Qing-Hai Ji; Qiang Shen; Yong-Xue Zhu; Ning Qu
Journal:  Gland Surg       Date:  2019-10

10.  [Lymph node dissection in papillary and follicular thyroid cancer].

Authors:  C Vorländer; R H Lienenlüke; R A Wahl
Journal:  Chirurg       Date:  2008-06       Impact factor: 0.920

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.